Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemtabrutinib With Venetoclax and Obinutuzumab in CLL
NCT07690891Phase 2Not yet recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 2 trial of nemtabrutinib in chronic lymphocytic leukemia (CLL), sponsored by Medical College of Wisconsin. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
nemtabrutinib
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT07690891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07690891.